DFDA

Antacids (e.g., Aluminum Hydroxide/Magnesium Hydroxide)

Treatment for Gastritis And Duodenitis

Typical Dosage: 10-20 mL as needed

Effectiveness
65%
Safety Score
82%
Clinical Trials
300
Participants
30K

Comparative Safety Scale(Higher is safer)

Cyanideâ˜ ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
82
DangerousModerateSafe
Treatment Details
Dosage Range
10-20 mL as needed
Time to Effect
Immediate (minutes)
Treatment Duration
As needed for symptoms
Evidence Quality
MODERATE
Number Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Confidence Score
70%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$120
Monitoring:$800
Side Effect Mgmt:$5
Total Annual:$925
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
QALYs Gained
0.05
Outcome-Based Costs
Cost per Responder
$192
Antacids (e.g., Aluminum Hydroxide/Magnesium Hydroxide) Outcomes

for Gastritis And Duodenitis

Efficacy Outcomes
Overall Effectiveness
+65%
Response Rate
+65%
Common Side Effects
Constipation (Aluminum-based)
+15%
Diarrhea (Magnesium-based)
+15%
Chalky taste
+5%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov